Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Idris

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Expert Review of Anti-Infective Therapy|July 8, 2024
Intranasal antivirals against respiratory syncytial virus: the current therapeutic development landscapeVictor Baba Oti, Adi Idris, Nigel A J McMillan
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Genetic deletion of HPV E7 oncogene effectively regresses HPV driven oral squamous carcinoma tumour growthDanyelle Assis Ferreira, Nigel A J McMillan, Adi Idris
Journal of Medical Virology|October 28, 2022
Analysis of a hit-and-run tumor model by HPV in oropharyngeal cancersDanyelle Assis Ferreira, Adi Idris, Nigel A J McMillan
EMBO Molecular Medicine|March 14, 2022
RNAi to treat SARS-CoV-2-variant proofing the next generation of therapiesNigel A J McMillan, Kevin V Morris, Adi Idris
Molecular Diagnosis & Therapy|April 5, 2022
Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic InterventionYusuf M Idres, Nigel A J McMillan, Adi Idris
International Journal of Adolescent Medicine and Health|August 8, 2017
The diurnal pattern of salivary IL-1β in healthy young adultsNur Basirah Ghazali, Michael Steele, David Koh, et al.
Microbial Pathogenesis|May 6, 2019
cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cellsMushfiq H Shaikh, Vuk Bortnik, Nigel Aj McMillan, et al.
Antiviral Research|October 25, 2024
SiRNAs as antiviral drugs - Current status, therapeutic potential and challengesTrairong Chokwassanasakulkit, Victor Baba Oti, Adi Idris, et al.
Drug Target Insights|June 25, 2015
Medicinal Plants: A Potential Source of Compounds for Targeting Cell DivisionIhsan N Zulkipli, Sheba R David, Rajan Rajabalaya, et al.
Nanoscale Advances|July 6, 2026
2-Aminophenylboronic acid-functionalized carbon dots show broad-spectrum antiviral activity against respiratory virusesMusbahu Adam Ahmad, Tufael Ahmed, Mochamad Zakki Fahmi, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Expert Review of Anti-Infective Therapy|July 8, 2024
Intranasal antivirals against respiratory syncytial virus: the current therapeutic development landscapeVictor Baba Oti, Adi Idris, Nigel A J McMillan
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Genetic deletion of HPV E7 oncogene effectively regresses HPV driven oral squamous carcinoma tumour growthDanyelle Assis Ferreira, Nigel A J McMillan, Adi Idris
Journal of Medical Virology|October 28, 2022
Analysis of a hit-and-run tumor model by HPV in oropharyngeal cancersDanyelle Assis Ferreira, Adi Idris, Nigel A J McMillan
EMBO Molecular Medicine|March 14, 2022
RNAi to treat SARS-CoV-2-variant proofing the next generation of therapiesNigel A J McMillan, Kevin V Morris, Adi Idris
Molecular Diagnosis & Therapy|April 5, 2022
Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic InterventionYusuf M Idres, Nigel A J McMillan, Adi Idris
International Journal of Adolescent Medicine and Health|August 8, 2017
The diurnal pattern of salivary IL-1β in healthy young adultsNur Basirah Ghazali, Michael Steele, David Koh, et al.
Microbial Pathogenesis|May 6, 2019
cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cellsMushfiq H Shaikh, Vuk Bortnik, Nigel Aj McMillan, et al.
Antiviral Research|October 25, 2024
SiRNAs as antiviral drugs - Current status, therapeutic potential and challengesTrairong Chokwassanasakulkit, Victor Baba Oti, Adi Idris, et al.
Drug Target Insights|June 25, 2015
Medicinal Plants: A Potential Source of Compounds for Targeting Cell DivisionIhsan N Zulkipli, Sheba R David, Rajan Rajabalaya, et al.
Nanoscale Advances|July 6, 2026
2-Aminophenylboronic acid-functionalized carbon dots show broad-spectrum antiviral activity against respiratory virusesMusbahu Adam Ahmad, Tufael Ahmed, Mochamad Zakki Fahmi, et al.
Pageof 9